↓ Skip to main content

A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer

Overview of attention for article published in Breast Cancer Research, September 2018
Altmetric Badge

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
75 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer
Published in
Breast Cancer Research, September 2018
DOI 10.1186/s13058-018-1015-x
Pubmed ID
Authors

Patrick Schöffski, Sara Cresta, Ingrid A. Mayer, Hans Wildiers, Silvia Damian, Steven Gendreau, Isabelle Rooney, Kari M. Morrissey, Jill M. Spoerke, Vivian W. Ng, Stina M. Singel, Eric Winer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 75 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 12%
Student > Ph. D. Student 8 11%
Student > Bachelor 8 11%
Researcher 6 8%
Other 5 7%
Other 15 20%
Unknown 24 32%
Readers by discipline Count As %
Medicine and Dentistry 12 16%
Pharmacology, Toxicology and Pharmaceutical Science 8 11%
Biochemistry, Genetics and Molecular Biology 7 9%
Nursing and Health Professions 6 8%
Chemistry 3 4%
Other 10 13%
Unknown 29 39%